Modified platelet factor-4

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) A61K 38/36 (2006.01) C07K 1/14 (2006.01) C07K 14/52 (2006.01) C07K 14/745 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2106629

Abstract The present invention is based of the discovery of two modified forms of human platelet factor-4, herein named MPF-4 and CPF-4, which were isolated from serum free culture medium of lipopolysaccharide-stimulated peripheral blood leukocytes. Amino acid sequence determination revealed that MPF-4 shares homology with platelet factor-4 beginning at N-terminal residue 17. CPF-4 consists of MPF- 4 disulfide bonded to the 16 N-terminal residues of platelet factor-4. Both MPF-4 and CPF-4 are potent inhibitors of endothelial cell proliferation, approximately 10-100 fold more potent than native or recombinant platelet factor-4, making them useful in the treatment of angiogenic diseases.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Modified platelet factor-4 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified platelet factor-4, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified platelet factor-4 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1585205

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.